Navigation Links
Personalizing medicine: New research shows potential of targeted therapies for cancer
Date:6/16/2008

NEW ORLEANS, La.A new study, presented at the SNM 55th Annual Meeting, shows the potential to pre-target the treatment of cancer cellsbringing personalized medicine one step closer from the laboratory to patients. By combining new molecular imaging techniques with targeted therapy, pretargeting offers cancer patients a more individualized treatment that can increase the effectiveness of therapies and minimize discomfort experienced during treatment.

In traditional radioimmunoimaging (RAII), radioisotopes are linked directly to antibodies and are delivered together to tumor targets. However, antibodies are relatively large molecules designed to remain in the bloodstream for a long period of time to fight infections, and their slow blood clearance can present difficulties when they are used to carry radioactive materials. The excessive blood-pool activity masks the radioisotope uptake in tumor lesions, thereby lowering the sensitivity and limiting the selectivity of traditional RAII.

"This study demonstrates the advantages of pretargetingan alternative strategy that uses a 'two-step' approach to the delivery of radioisotopeswhen applied to the imaging of tumors using a combination of radioisotope and antibody or RAII," said Otto Boerman, professor in the department of nuclear medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, and lead researcher of this study.

According to Boerman, in this process a bispecific monoclonal antibody (bsMAb), with one arm that recognizes a tumor-associated antigen and another arm that recognizes a peptide carrying an imaging agent, is given as a first injection. When the non-tumor-bound bsMAb has substantially cleared non-target tissues and has reached a maximum level in the tumor, the bsMAb-recognizable imaging agent is given. The latter agent either targets the bsMAb localized at the tumor or is rapidly removed in the urine. Because the delivery of imaging isotopes is rapid and is separated from the long antibody delivery process, radioisotope uptake in the tumor is significantly higher than in the blood, making pretargeting RAII an attractive alternative to traditional RAII.

"Pretargeting has applications beyond molecular imaging," said Boerman. "As has been demonstrated in this study, pretargeting with bsMAb can also be employed to improve the selective delivery of therapeutic isotopes, as well as cytotoxic drugs, to cancers. In fact, the major attribute of pretargeting is that the same bsMAb can be used for diagnostic imaging and therapy."

In this study, high specific uptake was obtained in human colon cancer cells transplanted in mice, resulting in very high tumor-to-blood and tumor-to-kidney ratios of radioisotope uptake. Additionally, PET/CT imaging of mice pretargeted with the bispecific antibody 16 hours earlier revealed excellent high-contrast images of CEA-expressing tumors within one hour after injection of the radionuclide gallium-68 (Ga-68)-labeled histamine-succinyl-glycine (HSG) peptide.

"When the imaging component of a pretargeting agent is used in concert with the therapeutic component, it permits the selection of a patient population that over-expresses a particular antigen, thus increasing these pre-screened patients' probability of responding to the therapeutic" said Boerman. "The prescreening of patients afforded by pretargeting prior to therapy represents a potential major advancement in the management of neoplastic diseases.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. The Changing Face of Medicine: National Medical Fellowships Annual Awards Gala Honors Three Fellows
2. Measuring medicine: How new technologies could help doctors predict patient outcomes
3. Stanford researchers find culprit in aging muscles that heal poorly
4. Children of depressed moms do better when dad is involved, SLU researcher finds
5. UCLA researchers identify markers that may predict diabetes in still-healthy people
6. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
7. New research shows how chronic stress worsens neurodegenerative disease course
8. New research explores newborn in-hospital weight loss
9. Research may unlock mystery of autisms origin in the brain
10. Bipolar disorder relapses halved by Melbourne researchers
11. HIVs impact in Zimbabwe explored in new research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
(Date:6/24/2016)... ... ... Finally, a bruise cream that really works. Originally designed to reduce ... post-surgical treatment plans of a variety of other procedures including, but not limited to, ... bruising and causes a rapid resolution of bruising and inflammatory changes compared to no ...
(Date:6/24/2016)... ... June 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located ... famous vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat ... Sedona as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology: